1. Stumvoll M，Gerich D.Clinical features of insulin resistance and beta cell dynfunction and the relationship to type 2 diabetes.Clin Lab Med，2001，21：31.

2. DeFronzo RA，Tobin JD，Andres R. Glucose clamp technique：a method for quantifying insulin secretion and resistance.Am J Physiol，1979，237（3）：E214.

3. Vauhkonen I，Niskanen L，Vanninen E，et al.Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.J Clin Invest，1998，101：86-96.

4. Fukushima M，Taniguchi A，Sakai M，et al. Homeostasis model assessment as a clinical index of insulin resistance：comparison with the minimal model analysis. Diabetes Care，1999，22：1911-1912.

5. Steil GM，Murrary J，Bergman RN，et al.Repeatability of insulin sensitivity and glucose effectiveness from the minimal model1 Implication for study design. Diabetes，1994，43：13652-3711.

6.洪洁，宁光，王笑薇，等.减少样本数的Bergman最小模型技术在胰岛素抵抗综合征中的应用.中华内分泌代谢杂志，2000，16：358-362.

7. Hermans MP，Levy JC，Morris RJ，et al.Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes，1999，48（9）：1779-1786.

8. Robert L H，Richard E P，Bogardus C，et al.Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol，2000，151：190-198.

9. The Diabetes Control and Complication Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized，controlled trial.Ann Intern Med，1998，128（7）：517-521.

10. Ahern B，Taborsky GJ JR，Havel PJ.Differential impairment of glucagons responses to hypoglycemia，arginine，and carbachol in alloxan-diabetic mice.Metabolism，2002，51：12-19.

11.李光伟.胰岛β细胞功能的评估.国外医学内分泌学分册，2003，23（3）：159.

12. Matthews D，Hosker J，Rudenski A，et al. Homeostasis model assessment：insulin resistanceand β-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia，1985，28：412-419.

13.陈家伦.循证医学对糖尿病诊断的贡献及目前存在的分歧.中华内分泌代谢杂志，2003，19（1）：1-4.

14.李光伟.少些完美多些自由—临床及科研工作中胰岛β细胞功能评估的困难与对策.中华内分泌代谢杂志，2003，19（1）：5-7.

15. Larsson H，Ahren B.Glucose dependent arginine stimulation test for characterization of islet function：studies on reproducibility and priming effect of arginine. Diabetologia，1998，41：772-777.

16.王玉磷，刘泽林.胰高糖素刺激试验在2型糖尿病患者中的应用价值.中华实用内科杂志，2004，24（2）：95-96.

17. Vilsboll T，Toft2Nielsen M B，Krarup T，et al.Evaluation of β-cell secretory capacity using glucagons like peptide 1.Diabetes Care，2000，23：807-812.

18. Grimberg A，Ferry R J，Kelly J A，et al.Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes，2001，50：322-328.

19. Stumvoll M，Fritsche A，Stefan N，et al.Evidence against a rate limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.J Clin Endocrinol Metab，2001，86：1235-1239.

20. Jonathan R，Martin J P，Jonathan C L，et al.Changes in amylin and amylin-like peptide concentrations and β-cell function in response to sulfonylurea or insulin therapy in NIDDM.Diabetes Care，1998，21：810-816.